Breaking News Instant updates and real-time market news.

COL

Rockwell Collins

$102.30

2.71 (2.72%)

, HON

Honeywell

$127.28

3.51 (2.84%)

09:56
04/21/17
04/21
09:56
04/21/17
09:56

Early notable gainers among liquid option names on April 21st

Notable gainers among liquid option names this morning include Rockwell Collins (COL) $103.22 +3.61, Honeywell (HON) $126.96 +3.20, Navient (NAVI) $16.29 +0.28, NextEra Energy (NEE) $133.16 +2.28, and Textron (TXT) $46.70 +0.80.

COL

Rockwell Collins

$102.30

2.71 (2.72%)

HON

Honeywell

$127.28

3.51 (2.84%)

NAVI

Navient

$16.01

0.9 (5.96%)

NEE

NextEra Energy

$134.01

3.135 (2.40%)

TXT

Textron

$46.71

0.8 (1.74%)

  • 21

    Apr

  • 21

    Apr

  • 21

    Apr

  • 24

    Apr

  • 09

    May

  • 18

    May

COL Rockwell Collins
$102.30

2.71 (2.72%)

03/20/17
FBCO
03/20/17
UPGRADE
FBCO
Outperform
Rockwell Collins upgraded to Outperform from Neutral at Credit Suisse
04/04/17
UBSW
04/04/17
NO CHANGE
Target $122
UBSW
Buy
Rockwell Collins price target raised to $122 from $108 at UBS
UBS analyst David Strauss raised his price target on Rockwell Collins (COL) to $122 from $108 on expectations the B/E Aerospace (BEAV) acquisition will close over the near-term, leading to higher earnings estimates and free cash flow. Strauss maintained his Buy rating on Rockwell Collins shares.
04/19/17
BARD
04/19/17
UPGRADE
Target $118
BARD
Outperform
Rockwell Collins upgraded to Outperform from Neutral at Baird
Baird analyst Peter Arment upgraded Rockwell Collins to Outperform from Neutral to reflect the recently closed acquisition of B/E Aerospace, which he views as having compelling accretion and cash flow generation. Arment believes investors should add or establish positions in Rockwell Collins below $100 per share and he raised his price target to $118 from $90.
03/20/17
03/20/17
UPGRADE
Target $120

Outperform
Rockwell Collins upgraded to Outperform at Credit Suisse
As previously reported, Credit Suisse analyst Robert Spingarn upgraded Rockwell Collins (COL) to Outperform from Neutral as he expects a series of positive catalysts over the next 12 months. The analyst also sees a "strong pro-forma financial profile" with the ability to quickly delever, and says the B/E Aerospace (BEAV) acquisition is not priced in. Spingarn raised his price target on Rockwell Collins' to $120 from $92.
HON Honeywell
$127.28

3.51 (2.84%)

12/13/16
UBSW
12/13/16
NO CHANGE
UBSW
Neutral
Earlier than expected Boeing 777 rate cut negative for suppliers, says UBS
UBS analyst David Strauss said that while Boeing (BA) had previously signaled a 777 production rate cut was coming, he thinks the now-announced cut to 5 planes per month in mid-2017 is 3 to 6 months earlier than expected. He sees the earlier than expected transition as having negative implications for key 777 suppliers, including B/E Aerospace (BEAV), GE (GE), Honeywell (HON), Spirit AeroSystems (SPR) and Triumph Group (TGI). Strauss keeps a Neutral rating on Boeing, as he believes 777X development will burn a couple billion per year with overall FCF declining during this period, but also said the company's 30% dividend increase and $14B buyback announcement signals strong confidence in its cash flow outlook.
03/02/17
OPCO
03/02/17
NO CHANGE
Target $148
OPCO
Outperform
Honeywell price target raised to $148 from $134 at Oppenheimer
Oppenheimer analyst Christopher Glynn raised his price target for Honeywell to $148 from $134 as OM track record exceeds new commitments, organic outlook appears conditioned by recent years' macro headwinds. Further, with defense spending set to turn and Honeywell indicating AM outgrowth of flight hours this year, the analyst thinks an upward tweak of Aero guide could materialize during 2017. He reiterates an Outperform rating on the shares.
02/21/17
JEFF
02/21/17
NO CHANGE
Target $141
JEFF
Buy
Honeywell price target raised to $141 from $133 at Jefferies
Jefferies analyst Howard Rubel raised his price target for Honeywell to $141 following a review of the company's annual filing. The 10-K highlights elements of profitability and cash flows, Rubel tells investors in a research note. He expects the non-U.S. business will continue to be more profitable show better growth. Rubel keeps a Buy rating on Honeywell.
12/19/16
OPCO
12/19/16
NO CHANGE
Target $134
OPCO
Outperform
Honeywell price target raised to $134 from $122 at Oppenheimer
Oppenheimer analyst Christopher Glynn raised his price target for Honeywell to $134 from $122, citing its 2017 outlook as he believes quality of drivers are set to improve. He reiterates an Outperform rating on the shares.
NAVI Navient
$16.01

0.9 (5.96%)

01/06/17
DADA
01/06/17
INITIATION
Target $21
DADA
Buy
Navient initiated with a Buy at DA Davidson
DA Davidson analyst Arren Cyganovich initiated Navient with a Buy and a $21 price target. The analyst believes Navient can use its scale and servicing expertise to win new portfolio acquisitions and expand into new areas, such as increasing its penetration into healthcare receivables management. He believes renewed attention to growth opportunities creates catalysts for shares. Additionally, the incoming Administration and Congress likely limits past regulatory/legislative risks and creates potential to drive new opportunities for the company ahead. Cyganovich thinks purchasing additional loan portfolios will help bridge the gap to further grow its non-education-related fee income as a proportion of overall revenues.
01/30/17
WEDB
01/30/17
INITIATION
Target $16.5
WEDB
Neutral
Navient initiated with a Neutral at Wedbush
Wedbush initiated Navient with a Neutral and a $16.50 price target.
01/17/17
JPMS
01/17/17
DOWNGRADE
Target $19
JPMS
Neutral
Navient downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Richard Shane downgraded Navient to Neutral from Overweight as he sees rising interest rates as a headwind. Shane keeps a $19 price target on Navient shares.
01/06/17
DADA
01/06/17
INITIATION
Target $21
DADA
Buy
Navient initiated with a Buy at DA Davidson
DA Davidson analyst Arren Cyganovich started Navient with a Buy rating and $21 price target. The company can use its scale in education loans to win new portfolio acquisitions and expand into new areas, the analyst contends.
NEE NextEra Energy
$134.01

3.135 (2.40%)

09/23/16
DBAB
09/23/16
DOWNGRADE
Target $131
DBAB
Hold
NextEra Energy downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Jonathan Arnold downgraded NextEra Energy to Hold saying he sees limited near-term upside with the shares up 23% year-to-date. "Extraordinarily frosty commentary" from two of three PUCT commissioners yesterday regarding NextEra's Oncor deal indicates an uphill battle in getting it approved, Arnold tells investors in a research note. Further, tax credit extensions may pressure the company's near-term renewables bookings, the analyst contends. He cut his price target for the shares to $131 from $133.
01/30/17
DBAB
01/30/17
UPGRADE
Target $33
DBAB
Buy
NextEra Energy Partners upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Jonathan Arnold upgraded NextEra Energy Partners (NEP) to Buy citing valuation and "supportive actions" from parent NextEra Energy (NEE). The analyst raised his price target for the shares to $33 from $29.
09/23/16
09/23/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Twitter (TWTR) downgraded to Underperform from Sector Perform by RBC analyst Mark Mahaney, who cut his price target to $14 from $17. The research firm's survey of more than 1,100 advertising professionals and their attitudes towards Facebook (FB), Google (GOOG), Twitter and other high-profile names showed that, despite marketing budgets continuing to shift online, interest in the microblog platform appears to be declining. Of note, Twitter shares have surged this morning after CNBC's David Faber reported that Twitter is moving closer to selling itself and has received expressions of interest in a possible sale, although no deal is imminent. 2. Yum! Brands (YUM) downgraded to Outperform from Top Pick by RBC Capital analyst David Palmer based on valuation. His price target on Yum shares remains $97. 3. Becton Dickinson (BDX) downgraded to Sell from Neutral by Citi analyst Amit Hazan, who thinks a cyclical U.S. slowdown will push the company's organic growth below expectations. The analyst, who also sees a diminishing impact on Becton's growth from emerging markets, cut his price target for the shares to $165 from $167. 4. NextEra Energy (NEE) downgraded to Hold from Buy by Deutsche Bank analyst Jonathan Arnold, as he sees limited near-term upside with the shares up 23% year-to-date. "Extraordinarily frosty commentary" from two of three PUCT commissioners yesterday regarding NextEra's Oncor deal indicates an uphill battle in getting it approved, Arnold tells investors. 5. AVANGRID (AGR) downgraded to Underweight from Neutral by JPMorgan analyst Christopher Turnure, who thinks both the company's growth guidance and consensus expectations "appear ambitious." He lowered his price target for the shares to $41 and $44 and notes he does not have confidence in AVANGRID's near-term growth. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/27/16
BOFA
09/27/16
NO CHANGE
BOFA
NextEra Energy added to US 1 List, Jack in the Box removed at BofA/Merrill
TXT Textron
$46.71

0.8 (1.74%)

04/20/17
BARD
04/20/17
NO CHANGE
Target $56
BARD
Outperform
Textron weakness a buying opportunity for long-term investors, says Baird
Baird analyst Peter Arment noted Textron reported a very soft margin performance in Q1 but said the outlook remains intact which supports the setup for operational improvements for the balance of 2017 and a return to the growth story at Textron Aviation in 2018. Arment said the weakness is a good buying opportunity for long-term investors and he reiterated his Outperform rating and $56 price target on Textron shares.
04/13/17
SPHN
04/13/17
INITIATION
Target $54
SPHN
Equal Weight
Textron initiated with an Equal Weight at Stephens
Stephens analyst Drew Lipke initiated Textron with an Equal Weight rating and $54 price target.
02/17/17
COWN
02/17/17
NO CHANGE
Target $60
COWN
Outperform
Textron earnings estimates intact with potential for upside, says Cowen
Cowen analyst Cai von Rumohr said Textron's business jet recovery may hold Q1 earnings below consensus, providing a better buying opportunity for the shares. He suggested seasonal factors could cause Q1 to be the weakest of the year and that full year 2017 earnings remain intact with a potential for upside if business jet business trends pick up. Rumohr reiterated his Outperform rating and $60 price target on Textron shares.
01/26/17
FBCO
01/26/17
NO CHANGE
Target $50
FBCO
Outperform
Credit Suisse sees buying opportunity after Textron results
Credit Suisse analyst Julian Mitchell sees a buying opportunity after Textron's Q4 results, noting that earnings are unlikely to stay frozen at $2.50 for long. While the analyst acknowledges that the company's 2017 is plagued by a number of mix headwinds, which are unlikely to persist into the medium-term, he points out that the stock rose by about 50% through year-end from where Textron closed after its earnings drop on Q4 earnings in January 2016. Mitchell reiterates an Outperform rating and $50 price target on the shares.

TODAY'S FREE FLY STORIES

FEYE

FireEye

$16.98

-0.16 (-0.93%)

, PANW

Palo Alto Networks

$141.75

-1.12 (-0.78%)

21:49
09/20/17
09/20
21:49
09/20/17
21:49
Hot Stocks
SEC discloses hack of Edgar system in 2016 »

Securities and Exchange…

FEYE

FireEye

$16.98

-0.16 (-0.93%)

PANW

Palo Alto Networks

$141.75

-1.12 (-0.78%)

QLYS

Qualys

$52.45

0.25 (0.48%)

CHKP

Check Point

$111.27

-1.71 (-1.51%)

PFPT

Proofpoint

$92.19

0.32 (0.35%)

FTNT

Fortinet

$38.24

-0.3 (-0.78%)

SYMC

Symantec

$33.72

-0.44 (-1.29%)

IMPV

Imperva

$44.45

-0.15 (-0.34%)

FFIV

F5 Networks

$116.83

0.07 (0.06%)

CUDA

Barracuda

$24.32

-0.15 (-0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

  • 29

    Sep

  • 05

    Oct

  • 06

    Oct

  • 10

    Oct

  • 18

    Oct

  • 19

    Oct

OMP

Oasis Midstream Partners

20:38
09/20/17
09/20
20:38
09/20/17
20:38
Syndicate
Oasis Midstream Partners 7.5M share IPO priced at $19.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

XLRN

Acceleron

$37.73

-1.24 (-3.18%)

20:37
09/20/17
09/20
20:37
09/20/17
20:37
Syndicate
Acceleron 5.405M share Secondary priced at $37.00 »

JPMorgan, Citi and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

IOVA

Iovance Biotherapeutics

$7.15

-1.4 (-16.37%)

19:46
09/20/17
09/20
19:46
09/20/17
19:46
Syndicate
Iovance Biotherapeutics 7.69M share Secondary priced at $6.50 »

The deal priced at $6.50,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 21

    Sep

SAFM

Sanderson Farms

$162.06

1.5 (0.93%)

, CAB

Cabela's

$61.45

0.07 (0.11%)

18:28
09/20/17
09/20
18:28
09/20/17
18:28
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P SmallCap 600…

SAFM

Sanderson Farms

$162.06

1.5 (0.93%)

CAB

Cabela's

$61.45

0.07 (0.11%)

TPRE

Third Point Reinsurance

$14.40

-0.1 (-0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDC

Western Digital

$86.37

-3.55 (-3.95%)

, TOSYY

Toshiba, also use TOSBF

$17.08

-0.29 (-1.67%)

18:26
09/20/17
09/20
18:26
09/20/17
18:26
Hot Stocks
Sandisk subsidiaries initiate new arbitration proceedings against Toshiba »

Western Digital (WDC)…

WDC

Western Digital

$86.37

-3.55 (-3.95%)

TOSYY

Toshiba, also use TOSBF

$17.08

-0.29 (-1.67%)

TOSBF

Toshiba, also use TOSYY

$2.87

-0.02 (-0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOA

North American Energy

$4.10

-0.05 (-1.20%)

18:26
09/20/17
09/20
18:26
09/20/17
18:26
Hot Stocks
North American Energy awarded two earthworks contracts for $90M »

North American Energy has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISTR

Investar Holding

$23.15

0.15 (0.65%)

18:01
09/20/17
09/20
18:01
09/20/17
18:01
Hot Stocks
Investar Holding raises quarterly dividend to 3c from 2c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BECN

Beacon Roofing

$47.86

-0.63 (-1.30%)

17:56
09/20/17
09/20
17:56
09/20/17
17:56
Syndicate
Beacon Roofing 6.325M share Secondary priced at $47.50 »

BofA/Merrill, RBC Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

AMD

AMD

$13.74

0.62 (4.73%)

, AMPH

Amphastar

$15.64

-0.02 (-0.13%)

17:46
09/20/17
09/20
17:46
09/20/17
17:46
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: AMD (AMD), up 6%…

AMD

AMD

$13.74

0.62 (4.73%)

AMPH

Amphastar

$15.64

-0.02 (-0.13%)

GVP

GSE Systems

$2.80

0.05 (1.82%)

MLHR

Herman Miller

DPS

Dr Pepper Snapple

$91.68

-0.12 (-0.13%)

JUNO

Juno Therapeutics

$45.21

1.41 (3.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 28

    Sep

ABMD

Abiomed

$157.42

0.32 (0.20%)

17:36
09/20/17
09/20
17:36
09/20/17
17:36
Hot Stocks
Abiomed receives FDA PMA approval for Impella RP for right heart failure »

Abiomed has received FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSK

Oshkosh

$79.69

0.34 (0.43%)

17:35
09/20/17
09/20
17:35
09/20/17
17:35
Hot Stocks
Oshkosh awarded $466.7M government contract modification »

Oshkosh Defense, Oshkosh,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AET

Aetna

$155.03

-1.01 (-0.65%)

17:32
09/20/17
09/20
17:32
09/20/17
17:32
Hot Stocks
Aetna president Lynch sells $2.5M of company shares »

The president of health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APRN

Blue Apron

$5.22

-0.29 (-5.26%)

17:25
09/20/17
09/20
17:25
09/20/17
17:25
Hot Stocks
Blue Apron jumps after meal kit competitor Plated acquired by Albertsons »

Earlier today, food…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPS

Dr Pepper Snapple

$91.68

-0.12 (-0.13%)

17:22
09/20/17
09/20
17:22
09/20/17
17:22
Earnings
Dr Pepper Snapple cuts FY17 EPS view to $4.53-$4.63 from $4.56-$4.66 »

FY17 consensus $4.63. In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBI

Hanesbrands

$24.64

-0.07 (-0.28%)

17:22
09/20/17
09/20
17:22
09/20/17
17:22
Downgrade
Hanesbrands rating change at Nomura Instinet »

Hanesbrands downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPRE

Third Point Reinsurance

$14.40

-0.1 (-0.69%)

, SAFM

Sanderson Farms

$162.06

1.5 (0.93%)

17:19
09/20/17
09/20
17:19
09/20/17
17:19
Hot Stocks
Breaking Hot Stocks news story on Third Point Reinsurance, Sanderson Farms »

Third Point Reinsurance…

TPRE

Third Point Reinsurance

$14.40

-0.1 (-0.69%)

SAFM

Sanderson Farms

$162.06

1.5 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAFM

Sanderson Farms

$162.06

1.5 (0.93%)

, CAB

Cabela's

$61.45

0.07 (0.11%)

17:18
09/20/17
09/20
17:18
09/20/17
17:18
Hot Stocks
Sanderson Farms to replace Cabela's in S&P 400 at open on 9/26 »

Bass Pro Shops is…

SAFM

Sanderson Farms

$162.06

1.5 (0.93%)

CAB

Cabela's

$61.45

0.07 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPCI

Intellipharmaceutics

17:14
09/20/17
09/20
17:14
09/20/17
17:14
Hot Stocks
Intellipharmaceutics receives Nasdaq non-compliance notice »

Intellipharmaceutics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

RWLK

ReWalk Robotics

17:13
09/20/17
09/20
17:13
09/20/17
17:13
Syndicate
Breaking Syndicate news story on ReWalk Robotics »

ReWalk Robotics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABM

ABM

$39.29

0.23 (0.59%)

17:11
09/20/17
09/20
17:11
09/20/17
17:11
Hot Stocks
Breaking Hot Stocks news story on ABM »

Thomas H. Lee Advisors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IVTY

Invuity

$8.35

-0.15 (-1.76%)

17:07
09/20/17
09/20
17:07
09/20/17
17:07
Hot Stocks
Breaking Hot Stocks news story on Invuity »

Discovery Group raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Nov

USG

USG

$31.26

1.84 (6.25%)

, CBPX

Continental Building

$25.60

1.25 (5.13%)

17:04
09/20/17
09/20
17:04
09/20/17
17:04
Hot Stocks
Gypsum stocks jump after peer National Gypsum announces price increase »

Shares of companies…

USG

USG

$31.26

1.84 (6.25%)

CBPX

Continental Building

$25.60

1.25 (5.13%)

EXP

Eagle Materials

$105.07

2.9 (2.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

TRHC

Tabula Rasa HealthCare

$25.66

-0.38 (-1.46%)

16:46
09/20/17
09/20
16:46
09/20/17
16:46
Recommendations
Tabula Rasa HealthCare analyst commentary at Piper Jaffray »

Tabula Rasa HealthCare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

16:40
09/20/17
09/20
16:40
09/20/17
16:40
General news
Fed Leans into Wind on Balance Sheet: »

Fed Leans into Wind on…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.